|
|
Profile
|
Delegates :
Yasufumi Murakami |
|
Incorporated :
March 22 , 2012 |
Paid in Capital :
148 Million yen |
Employees :
9 人 |
Address :
5-4-9 Kashiwanoha, Kashiwa-shi, CHIBA
〒277-0882
|
TEL/FAX :
+81-4-7157-4530 / +81-4-7157-4643 |
URL：
http://www.omr.co.jp |
Attachment :
|
Mission/Background :
Order-made Medical Research (OMR) was established to develop remedies and drugs for incurable diseases.
Our aims are
-\tDevelopment of antibody preparations for cancer
-\tDevelopment of companion diagnosis for various cancers
-\tEstablishment of research organization from target investigation to clinical study Phase I
|
|
Technology & Business
|
We have established an antibody production method, LIMAXYS, consisting of transplantation of
target expression cancer cell (patent US 8,598,408).
LIMAXYS enables us to produce antibodies that can bind the native form of membrane proteins.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Antibody creation for multi-pass transmembrane proteins
|
Service/Marketing
|
We can produce antibodies for proteins with small extracellular regions (e.g. GPCR).
|
Antibody production on collaboration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
We have succeeded in developing next generation LIMAXYS.
We also have established HTP screening system for antibody selection.
|
|
Alliance strategy
|
We are looking for companies to collaborate with.
|
|
|